Skip to content

Cryoport

US · CYRX #3336 by market cap Listed 2015
19.05 -0.50 -2.56%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Valuation each multiple against its own 5-year range

P/B ratio 2.32 Expensive vs history 86th percentile
5-year average 1.63 · #21 of 29 in Integrated Freight & Logistics
P/E ratio -20.09 Cheap vs history 14th percentile
5-year average -6.37 · forward -28.94
P/S ratio 5.24 Expensive vs history 83rd percentile
5-year average 3.81 · forward 4.74 · #31 of 32 in Integrated Freight & Logistics

Vs. peers Integrated Freight & Logistics

Company Market cap P/E (TTM) P/B Div yield
Cryoport (CYRX) 965.84M -19.24 2.22 0.00%
United Parcel Service (UPS) 90.44B 20.47 6.03 6.18%
FedEx (FDX) 71.19B 8.45 2.06 1.91%
Expeditors International (EXPD) 24.86B 24.47 10.62 0.82%
JB Hunt Transport Services (JBHT) 20.37B 30.82 5.61 0.82%
FEDEX FREIGHT HOLDING CO INC (FDXF) 17.72B 36.81 -70.35 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value18.64 Economic moatNone UncertaintyHigh

Trading 2.1% above Morningstar's fair value estimate.

Fair value

CryoPort Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 7% premium over our quantitative fair value estimate of $18.64 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's lack of profitability decreases our quantitative valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of -3.2%, which falls in the bottom 20% globally. The earnings generated by the company relative to its share price is concerning, which contributes to our view that shares are overvalued.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 45.0%, a core component of valuation, sits in the bottom 40% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Cryoport discussion 0 comments

Add a comment